Skip to main content
SpringerLink
Log in

Hepatic elimination of ACE inhibitors

  • Letters To The Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nakashima M, Yamamoto J, Shibata M, Uematsu T, Shinjo H, Akahori T, Shioya H, Sugiyama K, Kawahara Y (1992) Pharmacokinetics of temocapril hydrochloride, a novel angiotensin converting enzyme inhibitor, in renal insufficiency. Eur J Clin Pharmacol 43: 657–659

    Google Scholar 

  2. Hui KK, Duchin KL, Kripalani KJ, Chan D, Kramer PK, Yanagawa N (1991) Pharmacokinetics of fosinopril in patients with various degrees of renal function. Clin Pharmacol Ther 49: 457–467

    Google Scholar 

  3. Sica DA, Cutler RE, Parmer RJ, Ford NF (1991) Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency. Clin Pharmacokinet 20: 420–427

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Research Hypertension, Schwarz Pharma AG, Monheim, Germany

    H. Schulz

Authors
  1. H. Schulz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schulz, H. Hepatic elimination of ACE inhibitors. Eur J Clin Pharmacol 45, 589 (1993). https://doi.org/10.1007/BF00315321

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00315321

Keywords

Search

Navigation